Preservation reagent for cast-off cell nucleic acid in fecal sample, preparation method and detection kit
By leveraging the synergistic effect of PEG-modified branched polyethyleneimine and various protective components, the degradation problem of exfoliated cellular nucleic acids in fecal samples was solved, achieving efficient and stable nucleic acid extraction and making it suitable for the preservation and analysis of fecal samples.
Patent Information
- Application Number
- CN202411219861.9
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- Filing Date
- 2024-09-02
- Publication Date
- 2024-11-08
AI Technical Summary
Nucleic acid from exfoliated cells in fecal samples is easily degraded by factors such as enzymatic hydrolysis, oxidative stress, microbial contamination, and environmental pollution. Traditional preservation methods are costly, complex to operate, and have limited effectiveness.
Using PEGylated branched polyethyleneimine as the main component, combined with glycerol, antioxidants, preservatives and permeation regulators, a synergistic effect of multiple protective components is formed to improve nucleic acid stability and extraction efficiency.
It significantly improves the stability and extraction efficiency of nucleic acids, reduces degradation and damage, is suitable for different types of fecal samples and various downstream nucleic acid analysis methods, and ensures long-term preservation of nucleic acids under room temperature and low temperature conditions.
Smart Images

Figure CN118910221A_ABST
Abstract
Description
Technical Field
[0001] The present invention relates to the technical field of pharmaceutical detection preservation reagents, and in particular to a preservation reagent for exfoliated cell nucleic acid in a stool sample, a preparation method and a detection kit. Background Art
[0002] In modern medicine and biological research, stool sample analysis is becoming increasingly important. Stool samples contain a wealth of biological information, including microbiome data, DNA and RNA from exfoliated cells, which have extremely high research and application value in intestinal health, disease diagnosis, early cancer screening, and personalized medicine. However, the complexity and diversity of stool samples pose many challenges to the protection and extraction of nucleic acids.
[0003] Exfoliated cell nucleic acids in stool samples are susceptible to degradation due to a variety of factors. The main degradation factors include: 1. Enzymatic degradation: Feces contains a large amount of nucleases, which can quickly degrade DNA and RNA in exfoliated cells. Especially in a warm environment, the activity of nucleases is higher, resulting in faster nucleic acid degradation. 2. Oxidative stress: When stool samples are exposed to air, oxygen can cause oxidative damage to nucleic acids, further leading to degradation of DNA and RNA; 3. Microbial contamination: Feces contains a large number of bacteria and other microorganisms, which not only produce nucleases, but also multiply during sample storage, further accelerating the degradation of nucleic acids; 4. Environmental pollution: Fecal samples are easily affected by various chemicals and pollutants in the environment during collection, transportation and storage, which may also cause degradation and denaturation of nucleic acids.
[0004] At present, the traditional methods for nucleic acid protection and extraction of stool samples mainly include the following: Cryopreservation: Cryopreservation is the most common method for nucleic acid preservation. By rapidly freezing the sample to -20°C or lower, the activity of nucleases can be slowed down and the degradation of nucleic acids can be delayed. However, cryopreservation requires low-temperature equipment, and the transportation and storage costs are high. In addition, nucleic acids may still be degraded during the thawing process.
[0005] Chemical protectants: The use of chemical protectants such as ethanol, isopropanol or other nucleic acid stabilizers can protect nucleic acids from degradation to a certain extent. However, these chemicals may interfere with the subsequent nucleic acid extraction and analysis process, affecting the accuracy and reliability of the experimental results.
[0006] Physical protection methods: such as vacuum sealing and low-temperature drying, are also used for nucleic acid protection, but these methods are relatively complicated in actual operation and have limited protective effects on nucleic acids.
[0007] Commercial kits: There are some commercial kits on the market that are specifically used for nucleic acid extraction from stool samples. These kits usually combine chemical protective agents and special extraction methods to improve the efficiency and quality of nucleic acid extraction to a certain extent. However, these kits are expensive, and the effects may vary when facing different types of stool samples.
[0008] The protection and extraction of nucleic acids from exfoliated cells in stool samples face many challenges. Although traditional methods can alleviate these problems to a certain extent, they still have obvious limitations. PEG-modified branched polyethyleneimine (Chinese invention patent applied for by the applicant, application number: 2024108232852) is a new type of nucleic acid protection reagent. Through its unique molecular structure and multifunctional protection mechanism, it provides an innovative solution for the protection and extraction of nucleic acids in stool samples. Through further research and optimization of this application, PEG-modified branched PEI is expected to play an important role in biomedical research and clinical diagnosis, and promote the development and application of stool sample analysis technology. Summary of the invention
[0009] In order to solve the technical problems existing in the preservation of exfoliated cell nucleic acids in the above-mentioned stool samples, the purpose of the present application is to provide a preservation reagent for exfoliated cell nucleic acids in stool samples, which effectively solves the problem of protection and extraction of exfoliated cell nucleic acids in stool samples through the innovative application of PEG-modified branched PEI and the synergistic effect of multiple protective components, and significantly improves the stability, extraction efficiency and preservation performance of nucleic acids.
[0010] In order to achieve the above-mentioned purpose, the present invention adopts the following technical solutions: A preservation reagent for exfoliated cell nucleic acid in a stool sample, the preservation reagent comprising the following components: Polyethylene glycol modified branched polyethyleneimine: 2.0-5.0% Glycerin: 5.0-15% Tris(hydroxymethyl)aminomethane: 30-100 mM EDTA: 1-5 mM Sodium citrate: 5-20 mM Preservatives: 0.01-0.1% Antioxidants: 0.1-0.5% Osmotic regulator: 0.5-2.0%; The above percentages are by mass, and the pH value is adjusted to 7.3-7.5.
[0011] Preferably, the preservation reagent comprises the following components: Polyethylene glycol modified branched polyethyleneimine: 3.0-4.0% Glycerol: 8.0-12% Tris(hydroxymethyl)aminomethane: 40-80 mM EDTA: 2-4 mM Sodium citrate: 8-15 mM Preservatives: 0.02-0.05% Antioxidants: 0.2-0.4% Osmotic regulator: 0.8-1.5%.
[0012] Preferably, the preservative is sodium azide; the antioxidant is glutathione and ascorbic acid or a mixture of two thereof; and the osmotic regulator is a mixture of one or more of mannitol, trehalose, sucrose and glucose.
[0013] Preferably, the antioxidants are 0.2-1.0% glutathione and 0.2-1.0% ascorbic acid.
[0014] Preferably, the osmotic regulators are 0.5-1.0% mannitol and 0.5-1.0% trehalose.
[0015] Preferably, the preservation reagent also includes albumin BSA: 0.05-0.2%, 10-20 μL of protease inhibitor per milliliter of reaction system, and 20-40 units of RNase inhibitor per milliliter of reaction system.
[0016] Preferably, the polyethylene glycol-modified branched polyethyleneimine is prepared by using a branched polyethyleneimine having the following structural formula and a polyvinyl alcohol of 1000-3000 Da; the structural formula of the branched polyethyleneimine is as follows: ; n is 10-100.
[0017] Preferably, the preparation method of polyethylene glycol modified branched polyethyleneimine is as follows: 1) Dissolve 100g branched polyethyleneimine in 10L PBS and stir thoroughly until completely dissolved; dissolve 100g polyvinyl alcohol in 10L DMSO and stir thoroughly until completely dissolved; 2) Add 50 g EDC and 50 g NHS to the branched polyethyleneimine solution and stir for 2 hours to activate the amino groups; 3) Mix the activated branched polyethyleneimine solution with the PVA solution and stir at room temperature for 12-18 hours; 4) Perform dialysis through a dialysis bag to remove unreacted reagents and solvents. The dialysis process is carried out at 4°C. The dialysis solution is PBS. The dialysis lasts for 3 days, and the dialysis solution is replaced every day. 5) After dialysis is completed, the solution is freeze-dried to obtain bPEI-PVA copolymer.
[0018] Furthermore, the present invention also discloses a method for preparing a reagent for preserving exfoliated cell nucleic acid in a stool sample, the method comprising the following steps: 1) Dissolve Tris, EDTA and sodium citrate in pure water and adjust the pH to 7.4 to obtain a buffer solution; 2) Dissolve PEG-modified branched PEI in buffer and adjust the concentration to 2-5%; 3) Add glycerin, antioxidant, preservative, osmotic regulator and other reagents in sequence and mix thoroughly; 4) Sterilize the prepared reagents by passing them through a 0.22 µm filter; dispense into sterile containers and store them sealed at 4°C.
[0019] Furthermore, the present invention also discloses a kit for detecting nucleic acid of exfoliated cells in stool samples, the kit comprising a preservation reagent tube and the preservation reagent packaged in the preservation reagent tube.
[0020] The present invention has the following technical effects due to the adoption of the above technical solution: 1. The present invention uses PEGylated Branched PEI as the main component, and effectively improves the stability of nucleic acids through its unique molecular structure and chemical properties. PEGylated Branched PEI has efficient nucleic acid binding ability and can tightly bind to DNA and RNA in exfoliated cells to form a stable complex to prevent nucleic acid degradation during sample processing and storage. Experimental results show that the nucleic acid integrity and quality of fecal samples treated with the present invention are significantly better than those of traditional methods.
[0021] 2. The various protective ingredients contained in the present invention, such as glycerol, antioxidants (glutathione and ascorbic acid), stabilizers (albumin) and osmotic regulators (mannitol), can protect nucleic acids at multiple levels and reduce degradation and damage. The combination of these ingredients not only improves the stability of nucleic acids, but also optimizes the extraction process and reduces the impact of impurities and inhibitors. The results show that the nucleic acid extraction efficiency of the samples treated with the present invention is significantly improved, and the amount of extracted nucleic acid is more and the purity is higher.
[0022] 3. The protective reagent designed by the present invention can preserve stool samples for a long time at room temperature and low temperature, ensuring that the nucleic acid in the sample is not degraded during storage. The preservative (sodium azide) in the formula effectively prevents microbial contamination, and the antioxidant prevents oxidative stress from damaging nucleic acids. The experimental results show that the nucleic acid in the samples treated by the present invention still maintains good stability and integrity after being stored at 4°C and -20°C for several days and months, respectively.
[0023] 4. The design of the present invention takes into account the simplicity and feasibility of practical operation. At the sample collection site, the fecal sample can be directly placed in a container containing the protective reagent and gently shaken to mix. This simple and fast processing method reduces the time the sample is exposed to the external environment, avoids the degradation of nucleic acids, and improves the protective effect of nucleic acids.
[0024] 5. The present invention has good compatibility and is suitable for different types of stool samples and various downstream nucleic acid analysis methods, such as PCR, RT-PCR, sequencing, etc. Due to the good biocompatibility of PEG-modified branched PEI and other protective components, the present invention will not introduce significant interfering substances during the nucleic acid extraction process, ensuring that the extracted nucleic acid can be directly used for high-precision molecular biological analysis.
[0025] 6. The PEG-modified branched PEI in the present invention significantly reduces the toxicity of PEI through PEG modification, ensuring the safety of the reagent when treating biological samples. In addition, other ingredients in the formula, such as glycerol, glutathione, ascorbic acid, albumin and mannitol, are all compounds with good biocompatibility, further ensuring the biological safety of the reagent.
[0026] 7. Multiple experiments have verified the superior performance of the present invention. In comparative experiments, stool samples treated with the present invention were significantly superior to samples treated with traditional methods in terms of nucleic acid extraction, purity and stability. For example, PCR and RT-PCR experiments showed that nucleic acids extracted from samples treated with the present invention could be successfully amplified, and the quality and quantity of the amplified products reached a high level. In addition, long-term storage experiments showed that samples treated with the present invention could still obtain high-quality nucleic acids after being stored for several months, verifying its superior performance in long-term storage.
[0027] In summary, the present invention effectively solves the problem of protecting and extracting nucleic acids from exfoliated cells in fecal samples through the innovative application of PEG-modified branched PEI and the synergistic effect of multiple protective components, significantly improves the stability, extraction efficiency and preservation performance of nucleic acids, and has broad application prospects and important research value. BRIEF DESCRIPTION OF THE DRAWINGS
[0028] Figure 1The agarose gel electrophoresis detection results of Example 1, Example 4, Comparative Example 1, Comparative Example 3, and Comparative Example 4 of the present invention are shown. DETAILED DESCRIPTION
[0029] The following is a clear and complete description of the technical solutions in the embodiments of the present invention in conjunction with the embodiments of the present invention. Obviously, the described embodiments are only part of the embodiments of the present invention, not all of the embodiments. Based on the embodiments of the present invention, all other embodiments obtained by ordinary technicians in this field without creative work are within the scope of protection of the present invention.
[0030] The preparation method of polyethylene glycol modified branched polyethyleneimine (bPEI-PVA copolymer) is as follows: 1) Dissolve 100g branched polyethyleneimine (molecular weight less than 25000 Da) in 10L PBS and stir thoroughly until completely dissolved; dissolve 100g polyvinyl alcohol (1000-3000Da) in 10L DMSO and stir thoroughly until completely dissolved; 2) Add 50 g EDC and 50 g NHS to the branched polyethyleneimine solution and stir for 2 hours to activate the amino groups; 3) Mix the activated branched polyethyleneimine solution with the PVA solution and stir at room temperature for 12-18 hours; 4) Perform dialysis through a dialysis bag to remove unreacted reagents and solvents. The dialysis process is carried out at 4°C. The dialysis solution is PBS. The dialysis lasts for 3 days, and the dialysis solution is replaced every day. 5) After dialysis is completed, the solution is freeze-dried to obtain bPEI-PVA copolymer.
[0031] Example 1 PEGylated Branched PEI: 2.5% Glycerin: 10% Tris(hydroxymethyl)aminomethane (Tris): 50 mM Ethylenediaminetetraacetic acid (EDTA): 2 mM Sodium citrate: 10 mM Sodium azide: 0.01% Glutathione: 5 mM Ascorbic acid: 5 mM Albumin (Bovine serum albumin, BSA): 0.1% Mannitol: 1% The balance was pure water; the pH value was adjusted to 7.4.
[0032] The preparation method of the above-mentioned formula comprises the following steps: 1) Dissolve Tris, EDTA and sodium citrate in pure water and adjust the pH to 7.4 to obtain a buffer solution; 2) Dissolve the PEG-modified branched PEI in buffer; 3) Add glycerin, antioxidant, preservative, osmotic regulator and other reagents in sequence and mix thoroughly; 4) Sterilize the prepared reagents by passing them through a 0.22 µm filter; dispense into sterile containers and store them sealed at 4°C.
[0033] Example 2 PEGylated Branched PEI: 3.5% Glycerin: 8% Tris(hydroxymethyl)aminomethane (Tris): 50 mM Ethylenediaminetetraacetic acid (EDTA): 2 mM Sodium citrate: 10 mM Sodium azide: 0.01% Glutathione: 5 mM Ascorbic acid: 5 mM Mannitol: 1% The balance was pure water; the pH value was adjusted to 7.4.
[0034] The preparation method is as in Example 1.
[0035] Example 3 PEGylated Branched PEI: 4.0% Glycerin: 5% Tris(hydroxymethyl)aminomethane (Tris): 50 mM Ethylenediaminetetraacetic acid (EDTA): 2 mM Sodium citrate: 10 mM Sodium azide: 0.01% Glutathione: 5 mM Ascorbic acid: 5 mM Albumin (Bovine serum albumin, BSA): 0.1% Mannitol: 1% The balance was pure water; the pH value was adjusted to 7.4.
[0036] The preparation method is as in Example 1.
[0037] Example 4 PEGylated Branched PEI: 4.5% Glycerin: 12% Tris(hydroxymethyl)aminomethane (Tris): 40 mM Ethylenediaminetetraacetic acid (EDTA): 3 mM Sodium citrate: 12 mM Sodium azide: 0.02% Glutathione: 0.3% Ascorbic acid: 0.3% Albumin (Bovine serum albumin, BSA): 0.15% Trehalose: 1.0% The balance was pure water; the pH value was adjusted to 7.4.
[0038] The preparation method is as in Example 1.
[0039] Example 5 PEGylated Branched PEI: 5.0% Glycerin: 15% Tris(hydroxymethyl)aminomethane (Tris): 60 mM Ethylenediaminetetraacetic acid (EDTA): 4 mM Sodium citrate: 15 mM Sodium azide: 0.05% Glutathione: 0.4% Ascorbic acid: 0.4% Albumin (Bovine serum albumin, BSA): 0.2% Mannitol: 1.5% Trehalose: 0.5% The balance was pure water; the pH value was adjusted to 7.4.
[0040] The preparation method is as in Example 1.
[0041] Comparative Example 1 Tris(hydroxymethyl)aminomethane (Tris): 50 mM Ethylenediaminetetraacetic acid (EDTA): 2 mM Sodium citrate: 10 mM Sodium azide: 0.01% Mannitol: 1% The balance was pure water; the pH value was adjusted to 7.4.
[0042] The preparation method is as in Example 1.
[0043] Comparative Example 2 Tris(hydroxymethyl)aminomethane (Tris): 50 mM Ethylenediaminetetraacetic acid (EDTA): 2 mM Sodium citrate: 10 mM Sodium azide: 0.01% Glycerin: 10% The balance was pure water; the pH value was adjusted to 7.4.
[0044] The preparation method is as in Example 1.
[0045] Comparative Example 3 Glycerin: 10% Tris(hydroxymethyl)aminomethane (Tris): 50 mM Ethylenediaminetetraacetic acid (EDTA): 2 mM Sodium citrate: 10 mM Sodium azide: 0.01% Glutathione: 5 mM Ascorbic acid: 5 mM Albumin (Bovine serum albumin, BSA): 0.1% Mannitol: 1% The balance was pure water; the pH value was adjusted to 7.4.
[0046] The preparation method is as in Example 1.
[0047] Comparative Example 4 PEGylated Branched PEI: 1.0% Tris(hydroxymethyl)aminomethane (Tris): 50 mM Ethylenediaminetetraacetic acid (EDTA): 2 mM Sodium citrate: 10 mM Sodium azide: 0.01% The balance was pure water; the pH value was adjusted to 7.4.
[0048] The preparation method is as in Example 1.
[0049] Comparative Example 5 Glycerin: 10% Tris(hydroxymethyl)aminomethane (Tris): 50 mM Ethylenediaminetetraacetic acid (EDTA): 2 mM Sodium citrate: 10 mM Sodium azide: 0.01% Glutathione: 5 mM Ascorbic acid: 5 mM Albumin (Bovine serum albumin, BSA): 0.1% The balance was pure water; the pH value was adjusted to 7.4.
[0050] The preparation method is as in Example 1.
[0051] Test example Sample collection: Sufficient stool samples were collected from the same subject and divided into 10 portions.
[0052] Sample processing: The samples were processed using the methods of 5 embodiments and 5 comparative examples respectively.
[0053] Storage conditions: All samples were stored at 4°C for 1 week.
[0054] Nucleic acid extraction: Nucleic acid was extracted from all processed samples using a standard nucleic acid extraction kit.
[0055] Quality Inspection: Nucleic acid concentration and purity (260 / 280 ratio) were determined using a NanoDrop spectrophotometer.
[0056] Nucleic acid integrity was assessed using agarose gel electrophoresis.
[0057] PCR and RT-PCR experiments were performed to detect the amplification effect of nucleic acid.
[0058] Experimental Results Sample processing method Nucleic acid concentration (ng / µL) Purity (260 / 280 ratio) Nucleic acid integrity CR amplification effect Comparative Example 1 15.35 1.5 Obvious degradation weak Comparative Example 2 10.28 1.3 Obvious degradation none Comparative Example 3 12.76 1.4 Obvious degradation weak Comparative Example 4 20.47 1.6 Degradable weak Comparative Example 5 18.85 1.5 Degradable weak Example 1 45.75 1.8 Clear bands, almost no degradation powerful Example 2 50.17 1.9 Clear bands, no degradation Very strong Example 3 55.24 1.95 The bands are very clear and without degradation Very strong Example 4 58.34 2.0 The bands are very clear and without degradation Very strong Example 5 57.37 2.0 The bands are very clear and without degradation Very strong Data analysis 1. Nucleic acid concentration: In the samples treated with the control group, the nucleic acid concentration was low, indicating that the control group method was not effective.
[0059] In the samples treated in the examples, the nucleic acid concentration was significantly increased, indicating that the PEG-modified branched PEI protective agent significantly improved the efficiency of nucleic acid extraction.
[0060] 2. Purity (260 / 280 ratio): The purity of the comparative example is lower, indicating the presence of more protein or other impurities.
[0061] The purity of the examples is close to the ideal value (1.8-2.0), indicating that the extracted nucleic acid has high purity and less impurities.
[0062] 3. Nucleic acid integrity (agarose gel electrophoresis): The nucleic acid bands of the comparative example were scattered and significantly degraded.
[0063] The nucleic acid bands of the examples are clear, and the degradation phenomenon is significantly reduced, especially in Examples 3, 4 and 5, which have almost no degradation.
[0064] 4. PCR amplification effect: The PCR amplification effect of the control group was the weakest, indicating that the nucleic acid quality was poor.
[0065] The amplification effects of the examples are relatively strong, especially in Examples 3, 4 and 5, which have very good amplification effects, indicating that the PEG-modified branched-chain PEI protective agent has excellent effects in nucleic acid protection and extraction.
[0066] It can be seen from the experimental data that PEGylated Branched PEI as a protective agent can significantly improve the stability and extraction efficiency of exfoliated cell nucleic acids in stool samples, which is better than traditional protection methods. The nucleic acid concentration, purity, integrity and PCR amplification effect in the embodiment are significantly better than those in the comparative example, especially when the PEI content is 4.0%, 4.5% and 5.0%, the effect is best. These results demonstrate the superior performance of this formula in the protection and extraction of nucleic acids in stool samples, and provide important technical support for related research and applications.
[0067] The above is a description of the embodiments of the present invention. Through the above description of the disclosed embodiments, professionals and technicians in the field can implement or use the present invention. Various modifications to these embodiments will be apparent to professionals and technicians in the field. The general principles defined herein can be implemented in other embodiments without departing from the spirit or scope of the present invention. Therefore, the present invention will not be limited to these embodiments shown in this article, but will conform to the widest range consistent with the principles and novelties disclosed herein.
Claims
1. A reagent for preserving exfoliated cell nucleic acid in a stool sample, characterized in that: The preservation reagent includes the following components: Polyethylene glycol modified branched polyethyleneimine: 2.0-5.0% Glycerol: 5.0-15% Tris(hydroxymethyl)aminomethane: 30-100 mM EDTA: 1-5 mM Sodium citrate: 5-20 mM Preservatives: 0.01-0.1% Antioxidants: 0.1-0.5% Osmotic regulator: 0.5-2.0%; The above percentages are volume mass percentages, and the pH value is adjusted to 7.3-7.
5.
2. The reagent for preserving exfoliated cell nucleic acid in a stool sample according to claim 1, characterized in that: The preservation reagent includes the following components: Polyethylene glycol modified branched polyethyleneimine: 3.0-4.0% Glycerol: 8.0-12% Tris(hydroxymethyl)aminomethane: 40-80 mM EDTA: 2-4 mM Sodium citrate: 8-15 mM Preservatives: 0.02-0.05% Antioxidants: 0.2-0.4% Osmotic regulator: 0.8-1.5%.
3. A reagent for preserving exfoliated cell nucleic acid in a stool sample according to claim 1 or 2, characterized in that: The preservative is sodium azide; the antioxidant is glutathione and ascorbic acid or a mixture of two thereof; the osmotic regulator is mannitol, trehalose, sucrose and glucose or a mixture thereof.
4. The reagent for preserving exfoliated cell nucleic acid in a stool sample according to claim 3, characterized in that: The antioxidants used are 0.2-1.0% glutathione and 0.2-1.0% ascorbic acid.
5. The reagent for preserving exfoliated cell nucleic acid in a stool sample according to claim 3, characterized in that: The osmotic regulators used were mannitol 0.5-1.0% and trehalose 0.5-1.0%.
6. A reagent for preserving exfoliated cell nucleic acid in a stool sample according to claim 1 or 2, characterized in that: The preservation reagent also includes albumin BSA: 0.05-0.2%, protease inhibitors added per ml reaction system 10-20µL, RNase inhibitors added per ml reaction system 20-40 units.
7. The reagent for preserving exfoliated cell nucleic acid in a stool sample according to claim 1 or 2, characterized in that: The polyethylene glycol-modified branched polyethyleneimine is prepared by using the branched polyethyleneimine with the following structural formula and 1000-3000 Da polyvinyl alcohol; The structural formula of the branched polyethyleneimine is as follows: ; n is 10-100.
8. The reagent for preserving exfoliated cell nucleic acid in a stool sample according to claim 6, characterized in that: The preparation method of polyethylene glycol modified branched polyethyleneimine is as follows: 1) Dissolve 100g of branched polyethyleneimine in 10L of PBS and stir thoroughly until completely dissolved; dissolve 100g of polyvinyl alcohol in 10L of DMSO and stir thoroughly until completely dissolved; 2) Add 50 g of EDC and 50 g of NHS to the branched polyethyleneimine solution and stir for 2 hours to activate the amino groups; 3) Mix the activated branched polyethyleneimine solution with the PVA solution and stir at room temperature for 12-18 hours; 4) Dialysis was performed using a dialysis bag to remove unreacted reagents and solvents. The dialysis process was performed at 4°C in PBS solution for 3 days, with the dialysate replaced daily. 5) After dialysis is completed, the solution is freeze-dried to obtain bPEI-PVA copolymer.
9. The method for preparing a reagent for preserving exfoliated cell nucleic acid in a stool sample according to any one of claims 1 to 6, characterized in that: The method comprises the following steps: 1) Dissolve Tris, EDTA, and sodium citrate in pure water and adjust the pH to 7.4 to prepare a buffer solution. 2) Dissolve PEG-modified branched PEI in buffer and adjust the concentration to 2-5%; 3) Add glycerol, antioxidant, preservative, osmotic regulator and other reagents in sequence and mix thoroughly; 4) Sterilize the prepared reagent by passing it through a 0.22 µm filter; aliquot into sterile containers and store sealed at 4°C.
10. A kit for detecting nucleic acid in exfoliated cells in a stool sample, comprising a preservation reagent tube and the preservation reagent according to any one of claims 1 to 8 packaged in the preservation reagent tube.
